Wave Life Sciences, Inc. (WVE)
3.18
-0.17
(-5.07%)
USD |
NASDAQ |
Oct 23, 16:00
3.175
0.00 (0.00%)
After-Hours: 20:00
Wave Life Sciences Profit Margin (Quarterly) : -3.05K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.05K% |
| March 31, 2026 | -68.21% |
| December 31, 2025 | -308.4% |
| September 30, 2025 | -707.8% |
| June 30, 2025 | -580.2% |
| March 31, 2025 | -510.9% |
| December 31, 2024 | 34.93% |
| September 30, 2024 | |
| June 30, 2024 | -167.2% |
| March 31, 2024 | -251.7% |
| December 31, 2023 | -55.95% |
| September 30, 2023 | 14.21% |
| June 30, 2023 | -95.47% |
| March 31, 2023 | -212.0% |
| December 31, 2022 | -3.53K% |
| September 30, 2022 | -13.69K% |
| June 30, 2022 | -11.01K% |
| March 31, 2022 | -2.16K% |
| December 31, 2021 | -1.97K% |
| September 30, 2021 | -17.10% |
| June 30, 2021 | -1.40K% |
| Date | Value |
|---|---|
| March 31, 2021 | |
| December 31, 2020 | -305.0% |
| September 30, 2020 | -959.4% |
| June 30, 2020 | -1.34K% |
| March 31, 2020 | -1.14K% |
| December 31, 2019 | -2.37K% |
| September 30, 2019 | -1.73K% |
| June 30, 2019 | -549.8% |
| March 31, 2019 | -1.46K% |
| December 31, 2018 | -1.05K% |
| September 30, 2018 | -837.5% |
| June 30, 2018 | -735.7% |
| March 31, 2018 | -2.48K% |
| December 31, 2017 | -2.80K% |
| September 30, 2017 | -1.94K% |
| June 30, 2017 | -2.24K% |
| March 31, 2017 | -5.51K% |
| December 31, 2016 | -2.73K% |
| September 30, 2016 | -4.47K% |
| June 30, 2016 | -2.77K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -- |
| CorMedix, Inc. | 25.50% |
| Eloxx Pharmaceuticals, Inc. | -- |
| Breakthrough Chemistry, Inc. | -43.31K% |
| BioStem Technologies, Inc. | -113.6% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -57.16% |
| Return on Assets | -44.52% |
| Return on Invested Capital | -53.58% |
| Gross Profit Margin (Quarterly) | -4.27% |
| Operating Margin (Quarterly) | -3.25K% |
| Return on Net Operating Assets | -528.7% |